Presented by Ruth Hobson, ND | May 7, 2025 at 12 PM Pacific

In the intricate web of stress regulation, the hypothalamic-pituitary-adrenal (HPA) axis plays a pivotal role-but it doesn't act alone. Neurotransmitters and gut health are essential yet often overlooked factors in maintaining adrenal balance and resilience. This webinar is designed to provide healthcare practitioners with a comprehensive understanding of adrenal physiology, HPA axis regulation, and the interconnected systems that influence stress adaptation.

Join us as we explore the physiological mechanisms that govern HPA axis function, the phases of dysfunction, and the latest advancements in assessment tools, including diurnal rhythm evaluations and cortisol awakening response (CAR) testing. We'll take a deep dive into how neurotransmitters shape the stress response and how gut health can either support or disrupt HPA axis vitality.

By the end of this session, you'll have a well-rounded approach to optimizing adrenal function-leveraging neurotransmitter balance, gut health, and targeted testing to enhance patient care. Don't miss this opportunity to elevate your clinical expertise-register today!

Learning Objectives:

• Explore adrenal anatomy, physiology, and the key mechanisms that regulate a healthy HPA axis.
• Explore how the HPA axis adapts to stress and learn to identify key dysfunction patterns at different stages.
• Evaluate advanced assessment tools, including diurnal cortisol patterns and the cortisol awakening response (CAR).
• Discover how neurotransmitters and gastrointestinal health influence stress tolerance and HPA axis balance.
• Implement proven strategies to rebalance the HPA axis and strengthen patient resilience to stress.

Presented by Dr. Brandon M Lundell, DC, APC, IFMCP, DABCI, DAACA, NE, CAC | May 14, 2025 at 12 PM Pacific

Is giving someone exogenous testosterone really the best we can do? In this compelling one-hour webinar, Dr. Brandon M. Lundell, with over 20 years of functional medicine expertise, challenges conventional approaches to testosterone replacement therapy (TRT). There is no doubt low testosterone affects millions of men, but simply administering exogenous hormones fails to address root causes and often leads to dangerous side effects. In this part 2 of Dr. Lundell's hormone series, the epidemic of declining male hormonal health is thoroughly explored-from decreased sperm counts throughout the lifespan to rising infertility rates. Dr. Lundell will present the critical "why" behind low testosterone, including environmental endocrine disruptors, the gut-gonadal connection, inflammation, oxidative stress, and nutrient deficiencies. Through case studies and evidence-based protocols, participants will learn proper testing methodologies and natural interventions that restore hormonal balance without the risks of conventional TRT. Discover how diet, targeted supplementation, and lifestyle modifications can address the underlying causes of low testosterone and improve overall male hormonal health.

Learning Objectives:

• Identify the limitations and potential dangers of conventional TRT, including tissue accumulation, receptor shutdown, and the surprising increased risk of cancer and cardiovascular disease with too much testosterone.
• Examine the root causes of declining male hormonal health, including environmental endocrine disruptors, inflammation, oxidative stress, mitochondrial dysfunction and the gut-gonadal connection.
• Apply appropriate testing methodologies beyond basic blood work, including saliva testing, nutritional evaluations, and gastrointestinal assessments to identify underlying causes of low testosterone.
• Implement evidence-based natural interventions and fertility protocols proven to increase sperm counts, testosterone levels, and libido.
• Construct personalized treatment plans addressing nutrient deficiencies, inflammation, leaky gut, and oxidative stress to restore proper HPAG function without exogenous hormones.
• Evaluate case studies demonstrating successful transition from testosterone replacement to natural hormonal support, resulting in normalized, healthy endogenous production.

Presented by Ruth Hobson, ND | May 20, 2025 at 12 PM Pacific

Since the Women's Health Initiative (WHI) study, estrogen has been widely vilified, leading to fear and misconceptions about its role in health. However, estrogen itself is not inherently harmful-its metabolism and elimination determine its impact on overall well-being and breast health.

This presentation unravels the complexities of estrogen metabolism and the estrobolome, shedding light on how hormones are processed and cleared from the body. The essential role of urinary hormone and metabolite testing will be explored, offering insights into individual metabolic function. A deep dive into phase 1, 2, and 3 metabolism will provide healthcare providers and patients with practical strategies for optimizing estrogen balance through lifestyle modifications, nutrition, treatment sequencing, and targeted nutraceutical interventions.

By bridging the gap between fear and science, this presentation delivers a balanced perspective on estrogen, equipping attendees with the knowledge needed to support hormonal health with confidence.

Learning Objectives:

• Understand the impact of estrogen metabolism on overall well-being and dispel common misconceptions stemming from the WHI study.
• Learn how the gut microbiome influences estrogen metabolism and its role in hormonal balance.
• Gain insights into phase 1, 2, and 3 metabolism and how the body processes and eliminates estrogen.
• Discover how urinary hormone and metabolite testing can reveal an individual's unique metabolic function.
• Implement practical lifestyle, nutritional, and nutraceutical interventions to support healthy estrogen metabolism.

Presented by Cheryl Burdette, ND | May 22, 2025 at 11 AM Pacific

As clinicians when we order a lab test, it is generally because we expect a certain result. For example, you may meet with a patient who has significant GI distress and you are relatively sure they will present with some level of pathogenic bacteria, and yet when the stool test is received, the pathogens expected are not there. This does not mean that there was not a positive finding! In this lecture we will review the inflammatory potential of the lack of a healthy microbiome, SCFA and the additional clues sIgA, lactoferrin and other markers give us. We will examine the research that shows interaction with SCFA beyond the blood brain barrier, as well as interactions with beneficial flora, brain health, cardiovascular health and general immune regulation. We will look at the significant impact that microbial deficiencies create and other patterns that emerge from stool testing beyond dysbiosis.

Presented by Ruth Hobson, ND | June 13, 2025 at 11:05 AM Pacific

Join us for Fullscript Forward, a free, live, virtual event featuring industry leaders driving the future of healthcare and the field of whole person care.

This presentation explores the pathophysiology of breast cancer risk in menopause and introduces the HuMap™, a non-invasive tool for assessing urinary hormones and their metabolites. This presentation will explore phase I and phase II estrogen metabolism, emphasizing the significance of urinary hormone and metabolite testing for uncovering an individual's unique metabolic function. Assessing estrogen metabolite imbalance is a reasonable first step to developing an effective risk reduction strategy for these patients.